Rick Wise
Stock Analyst at Stifel
(4.29)
# 399
Out of 5,008 analysts
248
Total ratings
63.86%
Success rate
11.14%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Maintains: Buy | $40 → $46 | $40.51 | +13.55% | 8 | Sep 29, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $95 → $85 | $76.72 | +10.79% | 25 | Sep 22, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $115 → $118 | $99.06 | +19.12% | 16 | Sep 19, 2025 | |
| HTFL HeartFlow | Initiates: Buy | $35 | $34.99 | +0.03% | 1 | Sep 2, 2025 | |
| TMCI Treace Medical Concepts | Maintains: Hold | $9 → $6 | $6.00 | - | 9 | Aug 8, 2025 | |
| BAX Baxter International | Downgrades: Hold | $36 → $25 | $22.90 | +9.17% | 9 | Aug 4, 2025 | |
| LUNG Pulmonx | Maintains: Buy | $16 → $5 | $1.73 | +189.02% | 5 | Jul 31, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $280 → $224 | $192.53 | +16.35% | 8 | May 2, 2025 | |
| CNMD CONMED | Downgrades: Hold | $75 → $55 | $45.90 | +19.83% | 12 | Apr 28, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $135 → $145 | $133.02 | +9.01% | 21 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $24.39 | +14.80% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $32 | $18.07 | +77.09% | 6 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $60 | $52.15 | +15.05% | 6 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $48 | $34.13 | +40.64% | 13 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $120 | $95.90 | +25.13% | 17 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $440 | $369.24 | +19.16% | 16 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $170 → $155 | $188.89 | -17.94% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $525 → $610 | $440.94 | +38.34% | 17 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $170 → $190 | $150.25 | +26.46% | 14 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $82 | $72.16 | +13.64% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $102 | $74.49 | +36.93% | 2 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $85 → $87 | $98.33 | -11.52% | 11 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $9 → $12 | $6.46 | +85.76% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $59 → $75 | $86.79 | -13.58% | 1 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $24 | $14.52 | +65.29% | 7 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $390 → $90 | $15.01 | +499.60% | 4 | Oct 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $25 | $11.30 | +121.24% | 4 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $103 → $112 | $42.61 | +162.85% | 5 | Oct 2, 2020 |
Artivion
Sep 29, 2025
Maintains: Buy
Price Target: $40 → $46
Current: $40.51
Upside: +13.55%
Edwards Lifesciences
Sep 22, 2025
Maintains: Buy
Price Target: $95 → $85
Current: $76.72
Upside: +10.79%
Zimmer Biomet Holdings
Sep 19, 2025
Maintains: Buy
Price Target: $115 → $118
Current: $99.06
Upside: +19.12%
HeartFlow
Sep 2, 2025
Initiates: Buy
Price Target: $35
Current: $34.99
Upside: +0.03%
Treace Medical Concepts
Aug 8, 2025
Maintains: Hold
Price Target: $9 → $6
Current: $6.00
Upside: -
Baxter International
Aug 4, 2025
Downgrades: Hold
Price Target: $36 → $25
Current: $22.90
Upside: +9.17%
Pulmonx
Jul 31, 2025
Maintains: Buy
Price Target: $16 → $5
Current: $1.73
Upside: +189.02%
Becton, Dickinson and Company
May 2, 2025
Maintains: Buy
Price Target: $280 → $224
Current: $192.53
Upside: +16.35%
CONMED
Apr 28, 2025
Downgrades: Hold
Price Target: $75 → $55
Current: $45.90
Upside: +19.83%
Abbott Laboratories
Apr 17, 2025
Maintains: Buy
Price Target: $135 → $145
Current: $133.02
Upside: +9.01%
Mar 31, 2025
Initiates: Buy
Price Target: $28
Current: $24.39
Upside: +14.80%
Mar 5, 2025
Maintains: Buy
Price Target: $40 → $32
Current: $18.07
Upside: +77.09%
Feb 26, 2025
Maintains: Buy
Price Target: $72 → $60
Current: $52.15
Upside: +15.05%
Feb 13, 2025
Maintains: Buy
Price Target: $36 → $48
Current: $34.13
Upside: +40.64%
Feb 10, 2025
Maintains: Buy
Price Target: $115 → $120
Current: $95.90
Upside: +25.13%
Jan 29, 2025
Maintains: Buy
Price Target: $400 → $440
Current: $369.24
Upside: +19.16%
Jan 23, 2025
Maintains: Hold
Price Target: $170 → $155
Current: $188.89
Upside: -17.94%
Dec 5, 2024
Maintains: Buy
Price Target: $525 → $610
Current: $440.94
Upside: +38.34%
Nov 22, 2024
Reiterates: Buy
Price Target: $170 → $190
Current: $150.25
Upside: +26.46%
Oct 8, 2024
Initiates: Buy
Price Target: $82
Current: $72.16
Upside: +13.64%
Sep 30, 2024
Maintains: Buy
Price Target: $100 → $102
Current: $74.49
Upside: +36.93%
Aug 21, 2024
Maintains: Hold
Price Target: $85 → $87
Current: $98.33
Upside: -11.52%
Jul 16, 2024
Upgrades: Buy
Price Target: $9 → $12
Current: $6.46
Upside: +85.76%
Apr 26, 2024
Upgrades: Buy
Price Target: $59 → $75
Current: $86.79
Upside: -13.58%
Feb 5, 2024
Maintains: Hold
Price Target: $17 → $24
Current: $14.52
Upside: +65.29%
Oct 13, 2023
Maintains: Buy
Price Target: $390 → $90
Current: $15.01
Upside: +499.60%
Jun 21, 2023
Reiterates: Hold
Price Target: $25
Current: $11.30
Upside: +121.24%
Oct 2, 2020
Maintains: Hold
Price Target: $103 → $112
Current: $42.61
Upside: +162.85%